Pre-treatment with a human anti-CTGF monoclonal antibody (FG-3109; FibroGen, Inc., San Francisco, CA, USA) blocked ECM production induced with aqueous humour from glaucomatous donors in primary human TM cells isolated from glaucoma and normal subjects [20]. The gene discussed is CCN2; the disease is glaucoma.